Pancreatitis Clinical Trial
Official title:
Influence of Vater's Ampulla Morphology on Biliary Cannulation Rate, Complications and Advanced Biliary Cannulation Techniques
Determine the influence of the papilla's morphology on the various outcomes of endoscopic retrograde cholangiopancreatography (ERCP), namely on the success of biliary cannulation, on complications, and on the need to use rescue cannulation techniques;
1. Background
ERCP is an advanced procedure which is widely used in the diagnosis and treatment of a
variety of benign and malignant pancreatobiliary disorders1,2,3,4,5.
Selective cannulation of the common bile duct (CBD) is the most important and
challenging step in a biliary endoscopic retrograde cholangiopancreatography6,7.
However, in the first ERCP, even in experienced hands, biliary cannulation may fail in
up to 15 % - 35 % of cases when using standard methods alone8.
Since the first description of the "Vater's papilla" by Abraham Vater in 17209, the
variability in papillary morphology has been widely recognized10. The use of high
quality digital images has led to a clear need and desire to create an endoscopic
classification based on the papilla's morphology. During the last decade, several
authors have proposed different classifications in order to predict the success of
cannulation, complications and the need for more advanced cannulation
techniques11,12,13,14,15. However, all the proposed classifications, with the exception
of one, fail because they have not been submitted to a validation process. The only
validated one is the proposed by Haraldsson13, which still has the drawback of not
incorporating some of the papillary morphologies.
Given the need, our research group created a new classification (entitled "Viana
Classification") that not only incorporates more morphologies but was also validated in
due course.
Hence, the next step is to explore the potential implications of papillary morphology on
the success of biliary cannulation, complications resulting from ERCP and the need to
use rescue techniques (fistulotomy and double-guidewire cannulation) in the event of
failure of the standard cannulation.
2. Financial resources
All participants included in this study will perform ERCP, laboratory tests and other
complementary diagnostic tests after a duly justified medical prescription (the exact
same exams that the patient would do if there wasn't this study). Therefore, there are
no additional costs or consumption of hospital resources.
3. Ethical considerations
In this study, participants will be included after informed consent. Anonymity and
confidentiality will be safeguarded by assigning an individual numeric code. It will
also be explained the possibility of withdrawing from the study at any time, with the
guarantee of the total elimination of data. All researchers involved in the study will
adhere to the Rules of Ethical Conduct and Best Practices in order to comply with the
precepts of the Declaration of Helsinki, the Convention on Human Rights and Biomedicine,
the guidelines of the Council for International Organizations of Medical Sciences and
the Guide to Good Clinical Practice.
4. Statistical analysis
Qualitative variables will be summarized using absolute and relative frequencies, and
quantitative variables will be summarized using the mean and standard deviation or the
median and interquartile range, depending on their distribution profiles. The normality
of the quantitative variables will be assessed using the histogram distribution.
Relations between categorical variables will be assessed using a chi-square test and
Fisher´s exact test. Differences between two or more groups of independent non-normally
distributed quantitative variables will be evaluated using a Kruskal-Wallis test.
To explain the risk of pancreatitis, a binomial logistic regression model with multiple
predictors will be performed.
The null hypothesis will be rejected when the test statistics p-values are less than
<0.05. Statistical analysis, sample size calculation and graphics will be performed
using Stata software (StataCorp. 2015. Stata Statistical Software: Release 14. College
Station, StataCorp LP)
5. Expected results
The results from this study will contribute to a better understanding of the influence of
papillary morphology on cannulation difficulty. In the event of demonstrating that some
morphologies imply greater difficulty in cannulation, strategies may be created, such as the
use of ab initio rescue techniques, in order to improve the results of ERCP, namely the
cannulation rate.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03609944 -
SpHincterotomy for Acute Recurrent Pancreatitis
|
N/A | |
Not yet recruiting |
NCT04652271 -
International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
|
||
Completed |
NCT01441492 -
Pancreas Resection With and Without Drains
|
N/A | |
Recruiting |
NCT02196935 -
Los Angeles Prospective GI Biliary and EUS Series
|
||
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01545167 -
The North American Pancreatitis Study
|
N/A | |
Completed |
NCT04168801 -
Early Oral Refeeding in Mild Acute Pancreatitis
|
N/A | |
Recruiting |
NCT03334708 -
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
|
||
Completed |
NCT01824186 -
Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy
|
N/A | |
Terminated |
NCT00428025 -
Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients
|
Phase 4 | |
Completed |
NCT00639314 -
Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy
|
N/A | |
Recruiting |
NCT00160836 -
Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter
|
Phase 1 | |
Completed |
NCT00121901 -
Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?
|
Phase 3 | |
Completed |
NCT00999232 -
Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube
|
Phase 4 | |
Terminated |
NCT00419549 -
Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05095831 -
EUS Shear Wave for Solid Pancreatic Lesions.
|
||
Completed |
NCT03601325 -
Acute Pancreatitis: Study of Possible Etiologies and Risk Factors Affecting Outcome
|
||
Not yet recruiting |
NCT06133023 -
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts
|
N/A | |
Withdrawn |
NCT02465138 -
A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis
|
Phase 4 | |
Recruiting |
NCT02971475 -
ESWL Versus ESWL and Endoscopic Treatment
|
N/A |